[Oncologic after-care of patients with prostate cancer].
The aim of the examinations is the proof of the clinical value of the granulocyte phagocytosis test in the after-care of the palliatively treated patients with a carcinoma of the prostate. On the basis of the analysis of the own patient and the observation of the course the routine control of the granulocyte phagocytosis is recommended, since unspecific complication are recognized earlier and thus may be treated better.
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000359:Aftercare; D000368:Aged; D003131:Combined Modality Therapy; D006098:Granulocytes / Q000276:immunology; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D009367:Neoplasm Staging; D010166:Palliative Care; D010587:Phagocytosis; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
Zur onkologischen Nachsorge von Patienten mit einem Prostatakarzinom.